Ranitidine
Product Images NDC 67046-650

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 67046-650). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ranitidine Structural Formula (D79fa307 A4fa 4ded Af53 31df482510dc 01)

Ranitidine Structural Formula (D79fa307 A4fa 4ded Af53 31df482510dc 01)
Chemical structure of the active ingredient ranitidine hydrochloride, showing the molecular arrangement of its components including dimethylaminoethyl, furan, and nitroguanidine groups.*
FDA Label Image

Blister Of 30 Tablets (D79fa307 A4fa 4ded Af53 31df482510dc 02)

Blister Of 30 Tablets (D79fa307 A4fa 4ded Af53 31df482510dc 02)
Ranitidine 150 mg tablet packaging label from Contract Pharmacy Services-PA, featuring a 30-day blister pack with numbered slots for daily dosing. The label includes storage instructions and space for pharmacy fill details, lot number, expiration date, and medication strength. The packaging is designed for organized medication management and patient compliance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.